Carl Goldfischer Net Worth & Insider Trades
Carl Goldfischer - Director, Epizyme, Inc
What is Carl Goldfischer's Net Worth?
The current estimated net worth of Epizyme, Inc's Director, Carl Goldfischer, is estimated to be about $38.39M . Carl Goldfischer owns about 3,385,951 units of Epizyme, Inc common stock. In the last 9 years at Epizyme, Inc, Carl Goldfischer has sold an estimated value of $33.28M worth.
What is Carl Goldfischer's Past Insider Trading?
Carl Goldfischer's largest purchase order was 555,555 units , worth over $5M on January 12, 2016. Carl Goldfischer's largest sale order was 466,667 units , worth over $13.65M on February 12, 2014. In total, Carl Goldfischer has made about 17 transactions over 9 years of their time at Epizyme, Inc. Carl Goldfischer usually trades in June, with the busiest year in 2014. The most recent transaction was a purchase order of 5,000 units , worth over $60.35K on November 13, 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CARL GOLDFISCHER
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Carl Goldfischer's' Mailing Address?
- Mailing address is 161 West 61st Street New York NY 10022 NY
Epizyme, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Restricted Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Robert B. Bazemore Jr. | 2020 | $650,000 | - | $3,237,620 | $4,103,853 | $370,500 | $96,369 | $8,458,342 |
| Robert B. Bazemore Jr. | 2019 | $592,937 | - | $1,105,393 | $2,060,531 | $409,127 | $5,630 | $4,173,618 |
| Robert B. Bazemore Jr. | 2018 | $575,667 | - | - | $2,748,939 | $320,575 | $5,690 | $3,650,871 |
| Paolo Tombesi | 2020 | $460,000 | - | $250,006 | $750,730 | $174,800 | $48,198 | $1,683,734 |
| Paolo Tombesi | 2019 | $168,901 | - | $612,848 | $1,173,669 | $76,076 | $146,971 | $2,178,465 |
| Matthew E. Ros | 2020 | $447,982 | - | $250,006 | $750,730 | $174,800 | $11,271 | $1,634,789 |
| Matthew E. Ros | 2019 | $432,600 | - | $538,793 | $899,137 | $199,861 | $11,598 | $2,081,989 |
| Matthew E. Ros | 2018 | $420,000 | - | - | $1,099,576 | $187,100 | $12,214 | $1,718,890 |
| Dr. Shefali Agarwal | 2020 | $478,000 | - | $274,990 | $825,799 | $199,804 | $7,154 | $1,785,747 |
| Dr. Shefali Agarwal | 2019 | $463,500 | - | $894,607 | $1,255,325 | $265,122 | $8,652 | $2,887,206 |
| Dr. Shefali Agarwal | 2018 | $199,615 | $125,000 | - | $1,472,846 | $200,500 | $1,648 | $1,999,609 |
| Jeffery L. Kutok, M.D., Ph.D. | 2020 | $337,500 | $85,000 | $374,996 | $1,124,996 | $134,663 | $6,813 | $2,063,968 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1571498/000119312521138283/d839557ddef14a.htm
What are Epizyme, Inc's Past Insider Trades?
Epizyme, Inc's most recent insider trade came on April 13, 2022 by Jeffery Kutok who sold 2,741 units worth $2.47K . In the last 9 years, insiders at Epizyme, Inc have sold an estimated value of $156.28M and bought an estimated value of $381.12M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are David Mott, Director, Robert Copeland, President Research and CSO, and Andrew Singer, EVP & CFO .
Epizyme, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||